Brandon Carter‐Cooper

511 total citations
25 papers, 350 citations indexed

About

Brandon Carter‐Cooper is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Brandon Carter‐Cooper has authored 25 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Hematology and 5 papers in Oncology. Recurrent topics in Brandon Carter‐Cooper's work include Acute Myeloid Leukemia Research (10 papers), Cancer therapeutics and mechanisms (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Brandon Carter‐Cooper is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Cancer therapeutics and mechanisms (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Brandon Carter‐Cooper collaborates with scholars based in United States, Spain and India. Brandon Carter‐Cooper's co-authors include Rena G. Lapidus, Herman O. Sintim, Ashkan Emadi, Jipei Liao, Kevin J. Cullen, Hancai Dan, Zejia Yang, Seda S. Tolu, Eunice S. Wang and Laurie Ford and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brandon Carter‐Cooper

23 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandon Carter‐Cooper United States	13	222	104	70	65	36	25	350
Daniel A Luedtke United States	7	332 1.5×	145 1.4×	105 1.5×	37 0.6×	26 0.7×	10	436
Lata Chauhan United States	8	313 1.4×	116 1.1×	159 2.3×	57 0.9×	50 1.4×	15	489
Paloma Silva de Souza Brazil	12	194 0.9×	104 1.0×	114 1.6×	63 1.0×	23 0.6×	15	333
Jasper E. Neggers United States	9	337 1.5×	44 0.4×	98 1.4×	63 1.0×	22 0.6×	12	410
Yu Jia United States	8	259 1.2×	76 0.7×	44 0.6×	36 0.6×	14 0.4×	14	373
Linda Hogarth United Kingdom	14	387 1.7×	91 0.9×	152 2.2×	82 1.3×	31 0.9×	29	666
Stela Álvarez-Fernández Spain	8	216 1.0×	118 1.1×	83 1.2×	76 1.2×	26 0.7×	11	363
Hugh Giovinazzo United States	9	220 1.0×	149 1.4×	211 3.0×	31 0.5×	72 2.0×	16	474
Mandy Beyer Germany	13	360 1.6×	55 0.5×	120 1.7×	63 1.0×	40 1.1×	19	557
Ellen J. B. Derissen Netherlands	7	237 1.1×	63 0.6×	81 1.2×	44 0.7×	7 0.2×	8	356

Countries citing papers authored by Brandon Carter‐Cooper

Since Specialization

Citations

This map shows the geographic impact of Brandon Carter‐Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Carter‐Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Carter‐Cooper more than expected).

Fields of papers citing papers by Brandon Carter‐Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Carter‐Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Carter‐Cooper. The network helps show where Brandon Carter‐Cooper may publish in the future.

Co-authorship network of co-authors of Brandon Carter‐Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Carter‐Cooper. A scholar is included among the top collaborators of Brandon Carter‐Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Carter‐Cooper. Brandon Carter‐Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carter‐Cooper, Brandon, Chin Siang Ong, Eric B. Schneider, et al.. (2025). Lung adenocarcinoma–derived IFN-γ promotes growth by modulating CD8+ T cell production of CCR5 chemokines. Journal of Clinical Investigation. 135(17).

Carter‐Cooper, Brandon, et al.. (2024). Interaction of 6-Thioguanine with Aluminum Metal–Organic Framework Assisted by Mechano-Chemistry, In Vitro Delayed Drug Release, and Time-Dependent Toxicity to Leukemia Cells. Nanomaterials. 14(19). 1571–1571. 1 indexed citations

Bollino, Dominique, et al.. (2024). Dual targeting of glutamine and serine metabolism in acute myeloid leukemia. Frontiers in Oncology. 14. 1326754–1326754. 3 indexed citations

Bollino, Dominique, Anusha Ganapati Bhat, Xinrong Ma, et al.. (2024). Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma. SHILAP Revista de lepidopterología. 12(1). 19–19.

Yang, Zejia, Jipei Liao, Lisa M. Schumaker, et al.. (2022). Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology. 131. 105939–105939. 8 indexed citations

Bollino, Dominique, Xinrong Ma, Brandon Carter‐Cooper, et al.. (2022). Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine. Frontiers in Oncology. 12. 1035537–1035537. 3 indexed citations

Miguel‐Pérez, Diego de, Alessandro Russo, Muthukumar Gunasekaran, et al.. (2022). Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer. Cancer. 129(4). 521–530. 27 indexed citations

Emadi, Ashkan, Bandish Kapadia, Dominique Bollino, et al.. (2020). Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia. Leukemia. 35(7). 1907–1924. 23 indexed citations

Liao, Jipei, Zejia Yang, Brandon Carter‐Cooper, et al.. (2020). Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition. Clinical & Experimental Metastasis. 37(2). 283–292. 15 indexed citations

10.

Yang, Zejia, Jipei Liao, Brandon Carter‐Cooper, et al.. (2019). Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer. 19(1). 485–485. 32 indexed citations

11.

Opoku‐Temeng, Clement, Eun Yong Choi, Elizabeth Chang, et al.. (2019). Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice. EBioMedicine. 40. 231–239. 11 indexed citations

12.

Lapidus, Rena G., Brandon Carter‐Cooper, Alison Duffy, et al.. (2019). Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation. Cancer Chemotherapy and Pharmacology. 83(6). 1105–1112. 12 indexed citations

13.

Dayal, Neetu, et al.. (2019). Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors. European Journal of Medicinal Chemistry. 180. 449–456. 30 indexed citations

14.

Dayal, Neetu, Clement Opoku‐Temeng, Moloud Aflaki Sooreshjani, et al.. (2018). Dual FLT3/TOPK Inhibitor with Activity against FLT3-ITD Secondary Mutations Potently Inhibits Acute Myeloid Leukemia Cell Lines. Future Medicinal Chemistry. 10(7). 823–835. 18 indexed citations

15.

Ma, Xiaochu, Jie Zhou, Changhao Wang, et al.. (2017). Identification of New FLT3 Inhibitors That Potently Inhibit AML Cell Lines via an Azo Click-It/Staple-It Approach. ACS Medicinal Chemistry Letters. 8(5). 492–497. 15 indexed citations

16.

Wang, Changhao, Brandon Carter‐Cooper, Yixuan Du, et al.. (2016). Alkyne-substituted diminazene as G-quadruplex binders with anticancer activities. European Journal of Medicinal Chemistry. 118. 266–275. 22 indexed citations

17.

Carter‐Cooper, Brandon, Steven Fletcher, Dana Ferraris, et al.. (2016). Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone – A novel class of compounds with potent activity against acute myeloid leukemia cells. Bioorganic & Medicinal Chemistry Letters. 27(1). 6–10. 8 indexed citations

18.

Emadi, Ashkan, Mariola Sadowska, Brandon Carter‐Cooper, et al.. (2015). Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemia. Leukemia Research. 39(7). 719–729. 12 indexed citations

19.

Griffiths, Elizabeth A., Brandon Carter‐Cooper, Seda S. Tolu, et al.. (2014). Presence of Isocitrate Dehydrogenase (IDH) Mutations May Predict Clinical Response to Hypomethylating Agents in Patients with Acute Myeloid Leukemia (AML). Blood. 124(21). 3724–3724. 2 indexed citations

20.

Kondaskar, Atul, James C. Fishbein, Brandon Carter‐Cooper, et al.. (2012). Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepines. Bioorganic & Medicinal Chemistry. 21(3). 618–631. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact